that induce morphologic (4, 5) and biochemical (6) endometrial alterations relevant to uterine receptivity.
|
|
- Dina Warner
- 6 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY VOL. 70, NO. 2, AUGUST 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. 12 Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen Carlos Simón, M.D.,* Juan J. Garcia Velasco, M.D.,* Diana Valbuena, M.D., Jose A. Peinado, M.D., Carlos Moreno, M.D.,* José Remohí M.D.,* and Antonio Pellicer, M.D.* Valencia University, Valencia; Instituto Valenciano de Infertilidad Madrid, Madrid; and Laboratorios Serono, Madrid, Spain Received December 22, 1997; revised and accepted March 6, Supported by FISss 95/ 1352 and 96/1263 grants from the Spanish government, Madrid, Spain. Presented in part at the 48th Annual Meeting of the European Society of Human Reproduction and Embryology, Edinburgh, United Kingdom, June 22 25, Reprint requests: Carlos Simón, M.D., Instituto Valenciano de Infertilidad, Guardia Civil, 23, Valencia, Spain (FAX: ; IVI@FUTURNET.ES). * Instituto Valenciano de Infertilidad and Department of Pediatrics, Obstetrics and Gynecology, Valencia University. Instituto Valenciano de Infertilidad Madrid. Laboratorios Serono /98/$19.00 PII S (98)00140-X Objective: To analyze the effect on uterine receptivity of a decrease in E 2 levels during the preimplantation period with the use of a step-down regimen in high responders undergoing IVF. Design: Prospective controlled clinical study. Setting: The Instituto Valenciano de Infertilidad. Patient(s): High responders in whom at least one previous IVF attempt failed in which 3 4 good-quality embryos were transferred and E 2 levels were 3,000 pg/ml on the day of hcg administration. Intervention(s): Gonadotropins were administered according to two different protocols. Blood samples were collected and IVF was performed. Main Outcome Measure(s): Serum E 2 levels and reproductive outcome of IVF. Result(s): Estradiol levels on the day of hcg administration and throughout the preimplantation period and the number of oocytes collected were significantly lower with the use of the step-down regimen than during the previous failed in which the standard protocol was used. The fertilization rate was similar and the number of good-quality embryos transferred was comparable. However, the implantation and pregnancy rates were significantly improved in patients who underwent the step-down regimen compared with those who received the standard protocol. Conclusion(s): With the use of a step-down regimen with FSH in high responders, our clinical results demonstrate that uterine receptivity can be improved when E 2 levels are decreased during the preimplantation period. (Fertil Steril 1998; 70: by American Society for Reproductive Medicine.) Key Words: High responders, estradiol, step-down Since the introduction of IVF, there has been substantial improvement in ovulation induction, oocyte retrieval, fertilization capability, and embryonic development. However, the end point, which is to improve implantation rates and pregnancy rates (PRs) after the transfer of 3 4 embryos, remains elusive. Indeed, up to 90% of apparently healthy embryos that are transferred to the uterus are destined to vanish (1). We know from basic studies that the success of embryonic implantation relies on a perfect dialogue between good-quality embryos and a receptive endometrium. Although the importance of embryo quality in IVF has been demonstrated thoroughly and embryo quality has improved (2), the management of the uterine factor remains vague. Uterine receptivity is deteriorated during controlled ovarian hyperstimulation (COH) for IVF compared with hormone replacement therapy (HRT) and natural s (3). This is not surprising considering that the aim of ovulation induction drugs is to recruit more oocytes; as a consequence, supraphysiologic levels of steroid hormones are produced that induce morphologic (4, 5) and biochemical (6) endometrial alterations relevant to uterine receptivity. 234
2 Moreover, we and other investigators consistently have found even lower implantation rates per embryo replaced in patients undergoing IVF who have a high response to gonadotropins (7 10), although this contrasts with other reports wherein a high response has been associated with no change (11, 12) or increased implantation (13). We previously demonstrated that high serum E 2 levels ( 3,000 pg/ml) on the day of hcg administration in high responders, regardless of the number of oocytes retrieved and the serum progesterone levels, are detrimental to uterine receptivity without affecting embryo quality (9). Indeed, PRs and implantation rates in recipients of embryos derived from the oocytes of high responders are similar to those in normal responders (9). Further, we documented an increase in serum E 2 levels during the preimplantation period in high responders compared with normal responders, suggesting that this abnormal endocrine milieu could be responsible for impaired implantation (10). Following this research line, and in light of the fact that high levels of serum E 2 during the preimplantation period are deleterious to endometrial receptivity, we undertook the present study to determine whether uterine receptivity (as measured by implantation rates and PRs) could be improved in high responders undergoing IVF with the use of a stepdown regimen designed to decrease E 2 levels during the preimplantation period. MATERIALS AND METHODS Study Design This study included a total of 91 IVF s performed in 86 high responders treated at our institution between January 1, 1996, and July 31, The study was approved by our institution s ethics committee, and institutional review board approval was obtained contingent on volunteer assignment of the patients after the provision of complete information. Blind randomization was ruled out because we had reasonable evidence to believe that one treatment produces better results than the other, and this design was imposed for institutional review board approval. To be included in this study, patients had to have had at least one previous failed IVF attempt in which 3 4 goodquality embryos were transferred and the E 2 level was 3,000 pg/ml on the day that hcg was administered. These patients were classified as high responders, as previously described (14). During their next, the patients were informed about the possibility of being included in the two study groups (standard versus step-down protocol). Twentyfour patients were treated in 29 s with a step-down regimen that previously was used for other clinical situations (15), whereas 62 patients were treated in 62 s with the same standard protocol used in the previous. Written consent was obtained from all participants. Patients and Stimulation Protocol The causes of infertility for patients who entered an IVF program and who received the step-down regimen were as follows: in 13 cases (54.2%) there was male factor infertility, in 4 cases (16.7%) there was tubal infertility, and in 7 cases (29.1%) there was unexplained infertility. Among patients who received the standard regimen, 35 (56.4%) had male factor infertility, (6.4%) had tubal infertility, 3 (4.8%) had endometriosis, and 20 (32.4%) had unexplained infertility. The protocol for ovarian stimulation was initiated with pituitary desensitization by the administration of leuprolide acetate, 1 mg/d SC (Procrin; Abbot S.A., Madrid, Spain), starting in the luteal phase of the previous. Serum E 2 levels of 60 pg/ml (220 pmol/l) and negative findings on vaginal ultrasound (US) scans were used to define ovarian quiescence. For the step-down regimen, on day 1 of ovarian stimulation, 4 ampules of highly purified FSH (NeoFertinorm; Serono Laboratorios, S.A., Madrid, Spain) were administered. On day 2, 3 ampules were administered, and on days 3 and 4, 2 ampules were administered. Starting on day 5, 1 1 ampules of FSH were given on an individual basis according to 2 serum E 2 levels and transvaginal ovarian US scans. For the standard protocol, on days 1 and 2 of ovarian stimulation, 1 ampule of hmg (Pergonal; Serono Laboratorios) was administered together with 3 ampules of highly purified FSH. On days 3, 4, and 5 of ovarian stimulation, 1 ampule of hmg and 1 ampule of FSH were given to each patient. Beginning on day 6, hmg and FSH were administered on an individual basis according to serum E 2 levels and transvaginal ovarian US scans. In both protocols, the criteria for hcg administration (10,000 IU, Profasi; Serono Laboratorios) were the same. The criteria for hcg administration included the presence of 2 follicles measuring at least 19 mm in diameter and serum E 2 levels of 800 pg/ml (2.94 nmol/l). Leuprolide acetate and gonadotropin injections were discontinued the day of hcg administration. Oocyte retrieval was scheduled for hours after hcg injection and intravaginal micronized progesterone, 400 mg/d (Progeffik; Effik Laboratory, Madrid, Spain), was administered as luteal support. In Vitro Fertilization/Intracytoplasmic Sperm Injection The standard IVF/intracytoplasmic sperm injection procedure has been described previously (9, 10). Briefly, oocyte-cumulus complexes were evaluated under the dissecting microscope and classified. Oocyte-cumulus complexes were incubated at 37 C under 5% CO 2 in atmospheric air. Embryos were scored on the day of transfer according to their morphology under the dissecting microscope. Four types of embryos were established, ranging from types I IV. Type I embryos were the best and were defined as round and wellshaped blastomeres without fragments. Our policy for ET FERTILITY & STERILITY 235
3 TABLE 1 Reproductive outcome of the step-down versus the previous failed of IVF. Variable Previous (n 24) Step-down (n 24) P value Patient age (y) NS GnRH analogue (d) NS Days of treatment NS Ampules of gonadotropins NS E 2 level (pg/ml) 5, , No. of oocytes Fertilization rate (%) NS No. of embryos transferred NS No. of embryos frozen Pregnancy rate (%) Implantation rate (%) Note: Values are expressed as means SE unless otherwise indicated. NS not significant. TABLE 2 Reproductive outcome of the standard protocol versus the previous failed of IVF. Variable Previous (n 62) Standard protocol (n 62) P value Age (y) NS GnRH analogue (d) NS Days of treatment NS Ampules of gonadotropins NS E 2 level (pg/ml) 4, , NS No. of oocytes NS Fertilization rate (%) NS No. of embryos transferred NS No. of embryos frozen NS Pregnancy rate (%) Implantation rate (%) Note: Values are expressed as means SE unless otherwise indicated. NS not significant. was to select as many type I and type II embryos as possible; the remaining embryos were cryopreserved with 1, 2-propanediol and sucrose. Only patients with freshly transferred embryos were included in the study. Hormone Measurements Blood was drawn daily, starting with hcg administration (day 0) and continuing for 7 days (day 6). The samples were stored at 20 C in aliquots for subsequent E 2 analysis together in the same assay. Serum E 2 was measured using commercially available RIA kits (BioMérieux, Charbonniéres les Bains, France). The interassay and intraassay variability for E 2 at a concentration of 40 pg/ml was 2.8% and 4.3%, respectively. Statistical Analysis Data were expressed as means SEM. Comparisons between different s of the same patient (Tables 1 and 2) were performed with the use of the Student s t-test, except that PRs and implantation rates were compared with the use of the 2 test. Analysis of variance was used to compare the results of step-down versus standard protocols for different patients. Statistical significance was defined as P.05. Statistical analysis was performed with the use of the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL). RESULTS With the use of the step-down regimen, E 2 levels on the day of hcg administration were significantly lower in patients undergoing IVF compared with their own previous failed (1, versus 5, pg/ml, respectively; P.001). As expected, E 2 levels on the day of hcg administration in patients undergoing the same standard protocol as in the previous failed were similar (5, versus 4, pg/ml, respectively). Circulating levels of E 2 during the preimplantation period (days 0 6) with the step-down regimen also were decreased compared with the previous (Fig. 1). Estradiol levels were significantly (P.01) lower in terms of absolute values with the step-down regimen compared with the previous. Table 1 compares the outcome of 24 s of IVF with the use of the step-down regimens compared with the previous failed. The number of oocytes collected was lower with the step-down regimen than in the previous ( versus , respectively, P.001). Similar fertilization rates were obtained (74.2% versus 71.2%, respectively), and the number of good-quality embryos transferred was comparable ( versus , respectively). Nevertheless, the implantation rate and PR were 29.3% and 64.2%, respectively. Five s (17.2%) were cancelled because of an 80% decrease in E 2 levels, from 1,000 pg/ml to 200 pg/ml. Table 2 compares the reproductive outcome of 62 patients who underwent the same standard protocol as was used in their previous failed. All the parameters analyzed were similar to those of the previous (because the induction ovulation protocol was similar). However, the implantation rate and PR were 8.5% and 24.2%, respectively. No cancellations were recorded. In patients for whom at least one IVF attempt failed in which 3 4 good-quality embryos were transferred and E 2 levels were 3,000 pg/ml on the day of hcg administration, the step-down regimen and standard protocol were compared in the following (Table 3). Estradiol levels 236 Simón et al. Step-down regimen in high responders Vol. 70, No. 2, August 1998
4 FIGURE 1 Circulating levels of E 2 during the preimplantation period (days 0 6) in patients undergoing the step-down regimen (dashed line) versus the previous failed (solid line). Bars represent means SE. were significantly lower with the step-down regimen than with the standard protocol on the day of hcg administration (1, pg/ml versus 5, pg/ml, respectively; P.001), as well as throughout the preimplantation period. As expected, the number of oocytes collected was TABLE 3 Reproductive outcome of the step-down versus the standard protocol of IVF. Variable Step-down (n 24) Standard protocol (n 62) P value Age (y) NS No. of previous failed s GnRH analogue (d) NS Days of treatment NS Ampules of gonadotropins NS E 2 level (pg/ml) 1, , No. of oocytes Fertilization rate (%) NS No. of embryos transferred NS No. of embryos frozen NS Pregnancy rate (%) Implantation rate (%) Hyperstimulated patients (%) Note: Values are expressed as means SE unless otherwise indicated. NS not significant. lower with the step-down regimen than with the standard protocol ( versus , respectively; P.001). Nevertheless, similar fertilization rates were obtained (74.2% versus 76.1%, respectively), and the number of good-quality embryos transferred was comparable ( versus , respectively). However, the implantation rate and PR were significantly improved in patients who underwent the step-down regimen compared with those who were stimulated with the standard protocol (29.3% and 64.2% versus 8.5% and 24.2%, respectively; P.02 and P.0002, respectively). DISCUSSION Comparison of standard IVF and donor oocyte s reveals that COH, which is necessary to produce multiple embryos for IVF, inhibits embryo implantation by decreasing endometrial receptivity (3). This concept is proved further by analysis of implantation rates in patients undergoing IVF who donate some of their oocytes to HRT-treated recipients; with the same oocyte and embryo quality, endometrial receptivity and therefore implantation rates and PRs is better in the HRT-treated recipients (9). Ovarian hyperstimulation inhibits embryo implantation in humans and in mice (16) and rats (17). Controlled ovarian hyperstimulation is associated with supraphysiologic hormone levels compared with natural or HRT-treated s. High E 2 levels, which are known to be FERTILITY & STERILITY 237
5 interceptive (18), and altered E 2 progesterone ratios, which also are associated with the impairment of endometrial receptivity (19), are the main factors affecting endometrial receptivity in high responders (9, 10). These clinical observations are reinforced by the morphologic changes detected in the secretory endometrium of patients undergoing COH by histology (4) and scanning electron microscopy (5) as well as by the biochemical patterns found in the endometrial fluid in these patients compared with patients undergoing HRT (6). On the basis of these considerations, we designed a series of studies aimed at developing clinical strategies to improve endometrial receptivity while using COH to produce multiple embryos for IVF. In the present study, using high responders in whom endometrial receptivity is decreased significantly, we investigated the use of the step-down principle developed by Fauser et al. (15), which allowed us to stimulate follicles to full maturation using a decremental dose regimen while reducing the number of functionally active mature follicles. In addition, it has been shown that the different ovarian responses in high versus low responders to COH are related to the extent of FSH accumulation in the late follicular phase (20). Moreover, LH was not administered. The objective of this strategy was to produce a small FSH window. Initially, we had to reach the FSH threshold, then the doses of gonadotropins were reduced to obtain FSH levels that dropped below the FSH threshold. By mimicking the dynamics of FSH in natural s (21), we attempted to elicit the recruitment and maturation of a relatively small number of follicles while the rest of the cohort was driven to atresia; our main goal, however, was to decrease E 2 levels in this group of patients. As a consequence, patients in whom at least one IVF attempt failed in which 3 4 good-quality embryos were transferred and E 2 levels were 3,000 pg/ml on the day of hcg administration were voluntarily assigned either to repeat the same protocol or to undergo the step-down regimen. Estradiol levels on the day of hcg administration were significantly lower with the step-down regimen compared with the standard protocol (1, pg/ml versus 5, pg/ml, respectively, P.001). The implantation rate and PR were 29.3% and 64.2%, respectively, in patients undergoing the step-down regimen versus 8.5% and 24.2%, respectively, in those receiving the standard protocol (P.02 and P.0002, respectively). The standard protocol was our control to ensure that the results obtained in the next with the step-down approach were not simply because of the repetition of the procedure. These clinical results suggest that in high responders to COH, endometrial receptivity can be improved by lowering abnormally high E 2 levels. The major difficulty with the step-down regimen is to determine the individual FSH threshold in clinical practice because the threshold for administered FSH may differ as much as 10-fold for different patients (22). For this reason, five s (17.2%) were cancelled because the FSH threshold was not reached and follicle development was arrested, as demonstrated by an abrupt 80% decrease in the E 2 level. Although our experience is limited, all our cancellations were induced by decreasing the FSH dose to 1 or 1 ampule 2 after 6 days of treatment when extremely high follicle development was observed. Learning from this, we resolved the problem in the next. No cancellations were recorded when the FSH dosage was maintained at 1 1 ampules/d after day 6 of treatment, and it is known that maxi- 2 mum serum levels after IM injections correlate well with body weight (23). For an individualized approach, we need more knowledge about the pharmacokinetics of the purified and recombinant gonadotropins. The possible mechanism(s) responsible for our clinical observations remain unknown. However, there may be an altered regulation of steroid receptors in the human endometrium because in COH s a significant reduction in the nuclear receptors for progesterone and E 2 has been demonstrated in both glands and stroma (24). Further studies are needed to clarify this point. Moreover, this study does not consider secretory products other than ovarian steroids that may be altered. Nonetheless, our clinical data suggest that impaired endometrial receptivity in superovulated patients with high levels of E 2 can be improved by decreasing E 2 levels in the next, thereby increasing the implantation rate and PR. References 1. Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Assisted Reproductive Technology Registry. Fertil Steril 1996;66: Conaghan J, Hardy K, Handyside AH, Winston RML, Leese HJ. Selection criteria for human embryo transfer: a comparison of pyruvate uptake and morphology. J Assist Reprod Genet 1993;10: Paulson RJ, Sauer MV, Lobo RA. Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril 1990;53: Garcia JE, Acosta AA, Hsiu JG, Jones HW. Advanced endometrial maturation after ovulation induction with human menopausal gonadotrophin/human chorionic gonadotrophin for in vitro fertilization. Fertil Steril 1984;41: Bladford AJ, Najmabadi S, Paulson RJ. Ultrastructural characteristics of the luteal phase endometrium in donors undergoing controlled ovarian hyperstimulation. Fertil Steril 1997;67: Simón C, Mercader A, Frances A, Gimeno MJ, Polan ML, Remohí J, et al. Hormonal regulation of serum and endometrial IL-1, IL-1, and IL-1ra: IL-1 endometrial microenvironment of the human embryo at the apposition phase under physiological and supraphysiological steroid level conditions. J Reprod Immunol 1996;31: Pellicer A, Ruiz A, Castellví RM, Calatayud C, Ruiz M, Tarín JJ, et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum Reprod 1989;4: Tarín JJ, Pellicer A. Consequences of high ovarian response to gonadotrophins: a cytogenetic analysis of unfertilized human oocytes. Fertil Steril 1990;54: Simón C, Cano F, Valbuena D, Remohí J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum estradiol levels in high and normal responder patients. Hum Reprod 1995;10: Pellicer A, Valbuena D, Cano F, Remohí J, Simón, C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril 1996;65: Simón et al. Step-down regimen in high responders Vol. 70, No. 2, August 1998
6 11. Testart J, Belaisch-Allart J, Forman R, Gazengel A, Hazout A, Strubb N, et al. Influence of different stimulation treatments on oocyte characteristics and in vitro fertilizing ability. Hum Reprod 1989;4: Toner J, Brzyski R, Oehninger S, Veeck L, Simonetti S, Muasher S. Combined impact of the number of preovulatory oocytes and cryopreservation on IVF outcome. Hum Reprod 1991;6: Chenette PE, Sauer MV, Paulson RJ. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril 1990;54: Tarín JJ, Sampaio MC, Calatayud C, Castellví RM, Bonilla-Musoles F, Pellicer A. Relativity of the concept high responder to gonadotrophins. Hum Reprod 1992;7: Fauser BCJM, Donderwinkel P, School DC. The step-down principle in gonadotrophin treatment and the role of GnRH analogues. Baillieres Clin Obstet Gynaecol 1993:7: Fossum GT, Davidson A, Paulson RJ. Ovarian hyperstimulation inhibits embryo implantation in the mouse. J In Vitro Fertil Embryo Transfer 1989;6: Smith MG. On the interruption of pregnancy in the rat by injection of ovarian follicular extract. Johns Hopkins Hospital Bulletin 1926;39: McLean-Morris J, Van Wagenen G. Interception: the use of the preovulatory estrogens to prevent implantation. Am J Obstet Gynecol 1973;115: Gidley-Baird AA, O Neil C, Sinosich MJ, Porter RN, Pike IL, Saunders DM. Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progestrone/estrogen ratios in humans and mice. Fertil Steril 1986;45: Ben Rafael Z, Strauss JF, Mastroianni L, Flickinger GL. Differences in ovarian stimulation in HMG stimulated women may be related to FSH accumulation. Fertil Steril 1986;46: Hillier SG. Regulation of follicle estrogen biosynthesis: a survey of current concepts. J Endocrinol 1981;89: Brown JB. Pituitary control of ovarian function: concepts derived from gonadotrophin therapy. Aus N Z J Med 1978;18: Mannaerts B, Shoham Z, Schoot B, Bouchard P, Harlin J, Fauser B, et al. Single-dose pharmacokinetics and pharmacodynamics of recombinant human FSH (ORG 32489*) in gonadotropin-deficient volunteers. Fertil Steril 1993;59: Hadi FH, Chantler E, Anderson E, Nicholson R, McClelland RA, Seif MW. Ovulation induction and endometrial steroid receptors. Hum Reprod 1994;9: FERTILITY & STERILITY 239
Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles
Human Reproduction Vol.17, No.1 pp. 83 87, 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Joseph E.Peña, Peter L.Chang 1, Lai-King Chan, Khaled
More informationIncreasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo
FERTILITY AND STERILITY VOL. 76, NO. 5, NOVEMBER 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Increasing levels
More informationHIGH SERUM ESTRADIOL LEVELS ARE FERTILIZATION OUTCOME NOT DETRIMENTAL TO IN VITRO. Introduction SUMMARY
ORIGINAL ARTICLE HIGH SERUM ESTRADIOL LEVELS ARE NOT DETRIMENTAL TO IN VITRO FERTILIZATION OUTCOME Cheng-Hsuan Wu 1,2, Tsung-Cheng Kuo 3, Hsin-Hung Wu 1,2, Guang-Peng Yeh 1, Horng-Der Tsai 1 * 1 Division
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationreach levels up to 10 times or more those found during spontaneous cycles (2, 3).
Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization embryo transfer Mohamed F. M. Mitwally, M.D., a,c Helmata S.
More informationTheocharis Papageorgiou, Juliette Guibert, François Goffinet, Catherine Patrat, Yvonne Fulla, Yvette Janssens and Jean-René Zorn 1
Human Reproduction Vol.17, No.11 pp. 2846 2850, 2002 Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol
More informationAssociation of estradiol levels on the day of hcg administration and pregnancy achievement in IVF: a systematic review
Human Reproduction Vol.19, No.11 pp. 2446 2453, 2004 Advance Access publication October 7, 2004 doi:10.1093/humrep/deh473 Association of estradiol levels on the day of hcg administration and pregnancy
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationPediatrics, Obstetrics and Gynecology, University School of Medicine, Valencia University, Valencia, Spain
Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study María-José Escribá, Ph.D.,
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationIn Vitro Fertilization and Embryo Transfer
Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,
More informationSuperovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*
aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationASSOCIATION OF 17 β ESTRADIOL LEVELS ON THE DAY OF hcg ADMINISTRATION WITH PREGNANCY RATE IN IVF (IN VITRO FERTILIZATION) PATIENTS
ASSOCIATION OF 17 β ESTRADIOL LEVELS ON THE DAY OF hcg ADMINISTRATION WITH PREGNANCY RATE IN IVF (IN VITRO FERTILIZATION) PATIENTS Ravikant Soni 1, * Bushra Fiza 1, Rati Mathur 2 and Maheep Sinha 1 1 Department
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationEndometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY
Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Natural Cycle FET Protocol for endometrial preparation N FET, including modified N FET HRT FET:
More informationVery high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization
FERTILITY AND STERILITY Copyright 990 The American Fertility Society Printed on acid-free paper in U.S.A. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization
More informationLiyan Duan 1, Shihua Bao 1, Kunming Li 1, Xiaoming Teng 1, Ling Hong 1 and Xiaoyu Zhao 2. Abstract. Introduction
doi:10.1111/jog.13305 J. Obstet. Gynaecol. Res. Vol. 43, No. 6: 1037 1042, June 2017 Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationRelationship of progesterone/estradiol ratio on day of hcg administration and pregnancy outcomes in high responders undergoing in vitro fertilization
Relationship of progesterone/estradiol ratio on day of hcg administration and pregnancy outcomes in high responders undergoing in vitro fertilization Fa-Kung Lee, M.D., M.P.H., a,b Tsung-Hsuan Lai, M.D.,
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationComparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationThe long-acting gonadotropin-releasing hormone analogues impaired the implantation rate*
FERTILITY AND STERILITY Copyright c 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. The long-acting gonadotropin-releasing hormone analogues impaired the implantation
More informationIranian Journal of Reproductive Medicine Vol. 2. No.1 pp 29-33, 2004
Efficacy of Low Dose, Long-acting Gonadotropin Releasing Hormone Analogues (GnRH-a) Compared with Daily Injections of Short-acting GnRH-a in ART Cycles Robabeh Taheripanah M.D. 1, Mohammad A. Karimzadeh
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo
More informationRafael A. Cabrera, M.D., Laurel Stadtmauer, M.D., Ph.D., Jacob F. Mayer, Ph.D., William E. Gibbons, M.D., and Sergio Oehninger, M.D., Ph.D.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant
More information% Oocyte Donation Pregnancyes (days 3)
Ovulation induction in oocyte donors Roma- September 2007 Dr. José Remohí Dr. Carmen Rubio Dr. Amparo Mercader Dr. Pilar Alama Dr. Marco Melo Evolution of oocyte donation cycles 1500 1500 1000 58% 661
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationin vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationDepartment of Obstetrics and Gynecology, Changhua Christian Hospital, Institute of Medical Research, Chang Jung University, Changhua 500, Taiwan
Endocrine Journal 2005, 52 (4), 407 412 Relationship between Sex Hormone-Binding Globulin and Pregnancy Outcome in Women Undergoing Controlled Ovarian Hyperstimulation for Assisted Reproduction KUO-CHERNG
More informationProgramming in vitro fertilization for a 5- or 3-day week
Ass~st.d.reproductive tec"no'ogy FERTILITY AND STERILITY Copyright I[J 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Programming in vitro fertilization for a 5- or 3-day week
More informationMenstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
More informationThe Comparison of Clinical Outcomes between GnRH Agonist Long Protocol and GnRH Antagonist Short Protocol in Oocyte Donation Cycles
: 30 1 2003 Kor J Fertil Steril, Vol 30, No 1, 2003, 3 The Comparison of Clinical Outcomes between GnRH Agonist Long Protocol and GnRH Antagonist Short Protocol in Oocyte Donation Cycles Jeong Ho Rhee,
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationPituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H.
UvA-DARE (Digital Academic Repository) Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. Link to publication Citation for published version (APA): Mochtar, M. H.
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationImpact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer
CLINICAL ASSISTED REPRODUCTION Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer LUBNA PAL,1,3 JAN L. SHIFREN,2 KEITH B. ISAACSON,1 YuCHIAO CHANG,2 LUCY
More informationRelevance of LH activity supplementation
Relevance of LH activity supplementation in ovulation induction Franco Lisi Servizio di Fisiopatologia della Riproduzione Clinica Villa Europa Roma, Italia Comprehension of the role of LH in follicular
More informationProspective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in an in vitro fertilization program
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Prospective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in
More informationEffects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment
FERTILITY AND STERILITY VOL. 74, NO. 5, NOVEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effects of functional
More informationConception rate after in vitro fertilization in patients who conceived in a previous cycle
FERTILITY AND STERILITY Copyright
More informationENDOCRINE CHARACTERISTICS OF ART CYCLES
ENDOCRINE CHARACTERISTICS OF ART CYCLES DOÇ. DR. SEBİHA ÖZDEMİR ÖZKAN KOCAELI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, IVF UNIT 30.04.2014, ANTALYA INTRODUCTION The endocrine
More informationPituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H.
UvA-DARE (Digital Academic Repository) Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. Link to publication Citation for published version (APA): Mochtar, M. H.
More informationEndometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study
Reproductive BioMedicine Online (2010) 21, 50 55 www.sciencedirect.com www.rbmonline.com ARTICLE Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationOVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ; adm.cgmh.org.tw).
OVULATION INDUCTION Significantly superior response in the right ovary compared with the left ovary after stimulation with follicle-stimulating hormone in a pituitary down-regulation regimen Kuo-Chung
More information(1.,, ) (2.,,, )
33 11 Vol.33 No.11 2013 11 Nov. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.11.0749 E-mail: randc_journal@163.com IVF-ET 1 2 1 1 1 1 1 (1. 510150) (2. 510150) : (COH) (premature
More informationIvf day 6 estradiol level
Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3
More informationHana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang
Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile
More informationProf. Antonio Pellicer
Improving outcomes in ART : Time-lapse technology for monitoring COS and blastocyst culture Prof. Antonio Pellicer Instituto Valenciano de Infertilidad (IVI) University of Valencia apellicer@ivi.es www.ivi.es
More informationBo Sun Joo, Ph.D., a Sea Hee Park, M.S., a Byeong Min An, M.S., a Kyung Sue Kim, M.D., b Sung Eun Moon, M.D., b and Hwa Sook Moon, M.D., Ph.D.
Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner Bo Sun Joo, Ph.D., a Sea Hee Park, M.S.,
More informationORIGINAL ARTICLE Reproductive endocrinology
Human Reproduction, Vol.24, No.11 pp. 2902 2909, 2009 Advanced Access publication on August 11, 2009 doi:10.1093/humrep/dep290 ORIGINAL ARTICLE Reproductive endocrinology Does the estradiol level on the
More informationThe effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles
FERTILITY AND STERILITY Vol. 65, No.3, March 1996 Copyright t';, 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. The effects of prior gravidity on the outcomes of
More informationA Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist
1 *, ** * * * ** A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist Yoon Sung Nam, Nam Keun Kim*, Eun Kyung Kim**, Hyung Min Chung** and Kwang
More informationThe impact of HMG on follicular fluid hormone levels, embryo quality and IVF outcome
Eastern Journal of Medicine 19 (2014) 22-27 Original Article The impact of HMG on follicular fluid hormone levels, embryo quality and IVF outcome Gokce Anik Ilhan a,*, Gozde Erkanli Senturk a, Ozgur Oktem
More information08036-Barcelona, Spain. Fax: ;
RBMOnline - Vol 6. No 4. 427 431 Reproductive BioMedicine Online; www.rbmonline.com/article/859 on web 13 March 2003 Article Pregnancy after administration of high dose recombinant human LH alone to support
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationFactors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2015;42(2):67-71 Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles Ju Hee Park
More informationK.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1
Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and
More informationDepartment of Gynaecology and Reproductive Medicine, University Hospital, University of Western Ontario, London, Ontario, Canada
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationEvaluation of cycle-to-cycle variation of endometrial. responsiveness using transvaginal sonography in women undergoing assisted reproduction
Ultrasound Obstet Gynecol 2002; 19: 484 489 Evaluation of cycle-to-cycle variation of endometrial Blackwell Science, Ltd responsiveness using transvaginal sonography in women undergoing assisted reproduction
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationUtility of in vitro fertilization at diagnostic laparoscopy*
FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.
More informationUtility of color Doppler indices of dominant follicular
Ultrasound Obstet Gynecol 2002; 20: 592 596 Utility of color Doppler indices of dominant follicular Blackwell Science, Ltd blood flow for prediction of clinical factors in in vitro fertilization-embryo
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 79, NO. 1, JANUARY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More informationSerum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip
J MEDICINE 2013; 14 : 52-56 Serum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip MAGED M. YASSIN, 1 MOHAMMED
More informationSignificance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization*
FERTILITY AND STERILITY Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program
More informationArticle Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment
RBMOnline - Vol 7. No 2. 185 189 Reproductive BioMedicine Online; www.rbmonline.com/article/900 on web 18 June 2003 Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix,
More informationStudy on Several Factors Involved in IVF-ET of Human Beings
Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationSonographic determination of a possible adverse effect of domiphene citrate on endometrial growth
Human Reproduction vol.5 no.6 pp.670-674, 1990 Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth Yael Gonen 1 and Robert F.Casper Division of Reproductive
More informationThe association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age
Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G
More informationEgg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer
FERTILITY AND STERILITY Copyright tl 1989 The American Fertility Society Printed on acid-free paper in U. S.A. Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More information(BMI)=18.0~24.9 kg/m 2 ;
33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationA comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nadkarni PK et al. Int J Reprod Contracept Obstet Gynecol. 2015 Jun;4(3):617-621 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationJinan Bekir, M.D. Amma Kyei-Mensah, M.D. Seang-Lin Tan, M.D.
FERTILITY AND STERILITY Copyright ~ 1995 American Society for Reproductive Mediciue Vol. 64, No.4, October 1995 Printed on acid-free paper in U. S. A. Administration of progestogens to hasten pituitary
More informationLOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS
LOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS Salem H. H. '; Nassar A. M.,&l ; Askalany N. A. ', Kassem K. 1&4 Department of Obstetrics and Gynecology Al Azhar
More informationSerum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Amin KV et al. Int J Reprod Contracept Obstet Gynecol. 2018 Aug;7(8):3194-3198 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183316
More informationOutcome of IVF in DES-Exposed Daughters: Experience in the 90s
CLINICAL ASSISTED REPRODUCTION Outcome of IVF in DES-Exposed Daughters: Experience in the 90s LUBNA PAL,1,4 JAN L. SHIFREN,1 KEITH B. ISAACSON,1 YUCHIAO CHANG,2 MARTHA MAREAN,3 LUCY LEYKIN,1 and THOMAS
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationBulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t
FERTILITY AND STERILITY Copyright c 1992 The American Fertility Society Vol. 57, No.6, June 1992 Printed on acid-free paper in U.S.A. The outcome of in vitro fertilization and embryo transfer in women
More informationA rationale for timing of luteal support post GnRH agonist trigger. Address: IVF Unit, Elisha Hospital, 12 Yair Katz Street, Haifa, Israel,
Short Review: A rationale for timing of luteal support post GnRH agonist trigger Shahar Kol, IVF Unit, Elisha Hospital, Haifa, Israel. Address: IVF Unit, Elisha Hospital, 12 Yair Katz Street, Haifa, Israel,
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationInternational Journal of Women s Health and Reproduction Sciences Vol. 6, No. 2, April 2018, ISSN
http://www.ijwhr.net Open Access doi 10.15296/ijwhr.2018.31 Original Article International Journal of Women s Health and Reproduction Sciences Vol. 6, No. 2, April 2018, 187 191 ISSN 2330-4456 Comparison
More informationEstradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27
More information